Internet CME Policy
The Office of Continuing Medical Education (OCME) at the Johns Hopkins University School of Medicine is committed to protecting the privacy of its members and customers. Johns Hopkins maintains its Internet sites as an information resource and service for physicians, other health professionals and the public. Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet-based program. Your information will never be given to anyone outside these institutions. CME collects only the information necessary to provide you with the service you request.

Statement of Responsibility
The Johns Hopkins University School of Medicine takes responsibility for the content, quality and scientific integrity of this CME activity. 

 

Intended Audience: This activity is intended for gastroenterologists, physician assistants, nurse practitioners, and other treating patients with mild to moderate ulcerative colitis

Planner/Faculty Disclosure
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) and the Institute for Johns Hopkins Nursing to require the disclosure of the existence of financial relationships with industry form any individual in a position to control the content of a CME activity sponsored by OCME. Members of the Planning Committee are required to disclose all relationships, regardless of their relevance to the content of the activity. Faculty members are required to disclose only those relationships that are relevant to their specific presentations. The faculty reported the following:
 

No other planners have indicated that they have any financial interests or relationships with a commercial entity.

No other faculty members have indicated that they have any financial interests or relationships with a commercial entity whose products or services are relevant to the content of their presentation(s).
 

We conducted focused interviews and individual discussions with five eminent educator-clinicians who specialize in the treatment of ulcerative colitis and in health communications. Clinicians working with UC patients need an educational program to facilitate changes in attitudes and practice as it applies to improving their patient's persistence, adherence and compliance to adherence to UC therapy.

 

A survey of physicians was conducted to gain a more in-depth understanding of their educational need for improving their patients' persistence, adherence and compliance to UC therapy. Responses revealed that more than half of the clinicians believed that 25%-50% of their patients being treated for UC were nonadherent and non-persistent with treatment prescribed and that this sometimes/often resulted in treatment failure. However, more than half of the clinicians reported that they did not "always" discuss treatment adherence and persistence with their UC patients. These clinicians (82%) indicated that they would attend an educational activity that focused on improving treatment persistence and adherence among their patients with mild to moderate UC.

 

An in-depth review of the medical literature including national and regional measures, on ulcerative colitis and persistence, adherence, and compliance to therapy reveals that there is a broad range of medical therapies available for managing UC. Research reports that patients who are symptomatic and have more severe UC tend to adhere to their medication regimens. However, adherence/persistence rates of outpatients with quiescent UC to maintenance therapy are poor. Adherence and persistence to treatment among patients with UC is complex and a challenge for clinicians, with factors varying among patients and changing over time. However, there are strategies and tools that the clinician can use to improve the UC patients' adherence and persistence to treatment.

 

The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

There are no fees for participating in this CME activity. To receive credit, participants must (1) read the learning objectives and disclosure statements, (2) complete the educational activity, and (3) complete the posttest and activity evaluation form, including the certificate information section.

 

To obtain a certificate, participants must receive a score of 70% or better on the posttest. The posttest can be accessed at the end of the activity. Please e-mail any questions to info@paceuc.org.

I certify that I am participating in this Johns Hopkins University School of Medicine activity for CME-accredited training and/or educational purposes.

 

I understand that while I am participating in this capacity, I may be exposed to "protected health information," as that term is defined and used in Johns Hopkins policies and in the federal HIPAA privacy regulations (the "Privacy Regulations").  Protected health information is information about a person's health or treatment that identifies the person.  I also understand that while I am participating in this capacity I will be treated as a temporary member of Johns Hopkins for purposes of the Privacy Regulations only.

 

I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential.  

 

I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality.  The contact information is:  Johns Hopkins Privacy Officer, telephone: 410-735-6509, e-mail: HIPAA@jhmi.edu.

 

 

 

Johns Hopkins University School of Medicine

Office of Continuing Medical Education

Turner 20/720 Rutland Avenue                                       Reviewed & Approved by:

Baltimore, Maryland 21205-2195                                    General Counsel, Johns Hopkins Medicine (4/1/03)   Updated 4/09

Pentium 800 processor or greater, Windows 98/NT/2000/XP/7 or Mac OS 9/X, Microsoft Internet Explorer 5.5 or later, 56K or better modem, Windows Media Player 9.0 or later, 128 MB of RAM, sound card and speakers, Adobe Acrobat Reader, storage, Internet connectivity, and minimum connection speed. Monitor settings: High color at 800 x 600 pixels